Flu 5
Flu 5
Flu 5
http://www.nfid.org/idinfo/influenza
• Influenza is a serious infection that
affects between 5-20% of the
US population annually.
http://www.nfid.org/idinfo/influenza
• During the 2017-2018 season:
An estimated 900,000
individuals were hospitalized
Nearly 80,000 deaths
Occurred in the US from flu and flu-
related complications.
http://www.nfid.org/idinfo/influenza
• In temperate climates:
Seasonal epidemicsoccur mainly during
winter
• In tropical regions:
Influenza may occur throughout the year,
causing outbreaks more irregularly.
• Incubation period, is about 2 days, but
ranges from one to four days
• Influenza A viruses are further classified
into subtypes according to the
combinations of the hemagglutinin (HA)
and the neuraminidase (NA), the
proteins on the surface of the virus.
http://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal)
• Currently circulating in humans
subtype A(H1N1) are and
influenza viruses. A(H3N2)
• Only influenza type A viruses are known
to have caused pandemics.
http://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal)
• Influenza B viruses are not classified into
subtypes, but can be broken down into
lineages.
• Currently circulating influenza type B
viruses belong to either B/Yamagata or
B/Victoria lineage.
• Influenza C virus is detected less
frequently and causes mild
usually
infections, thus does not present public
health importance.
Epidemiology
• All age groups can be affected but
there are groups that are more at risk
than others.
• Pregnant women
• Children under 59 months
• The elderly
• Individuals with:
Chronic medical conditions (such as
chronic cardiac, pulmonary, renal, metabolic,
neurodevelopmental, liver or hematologic
diseases)
Immunosuppressive conditions
(such as HIV/AIDS, receiving chemotherapy or
steroids, or malignancy).
•
Health care workers are at high
risk acquiring influenza virus
infection
due to increased exposure to
the patients
risk further spread particularly
to vulnerable individuals.
Transmission
• Seasonal influenza spreads easily,
with rapid transmission in
crowded areas including schools
and nursing homes.
• Infect persons in close
proximity who breathe these
droplets in.
• The virus can also be spread by
hands contaminated with
influenza viruses.
• To prevent transmission, people should:
Cover their mouth and nose with a
tissue when coughing
Wash their hands regularly
Signs and symptoms
• Seasonal influenza is characterized by
a sudden onset of :
Fever Muscle and Joint pain
Cough Severe malaise
(usually dry)
Headache Sore throat
Runny nose
Diagnosis
• The majority of cases of human
influenza are clinically diagnosed
• Other respiratory viruses that can present
as Influenza-like Illness (ILI) include:
Rhinovirus
Respiratory syncytial virus
Parainfluenza
Adenovirus
Laboratory confirmation
• Throat, nasal and nasopharyngeal
secretions or tracheal aspirate or
washings is commonly performed
• Direct antigen detection
• Virus isolation
• Detection of influenza-specific RNA
by reverse transcriptase-polymerase
chain reaction (RT-PCR).
WHO recommended surveillance standards, Second edition
.
Treatmen
t seasonal influenza:
• Uncomplicated
Not from a high risk group
Symptomatic treatment
if symptomatic
Stay home in order to
minimize the
risk of infecting others in the
community
Group at high risk
• Severe or progressive clinical illness
(associated with suspected or confirmed
influenza virus infection)
Clinical syndromes of :
Pneumonia
Sepsis
Exacerbation of chronic
underling diseases
Antiviral drug
• Neuraminidase inhibitors (i.e. Oseltamivir)
as soon as possible (ideally, within 48
hours following symptom onset) to
maximize therapeutic benefits.
A minimum of 5 days, but can be
extended until there is satisfactory clinical
improvement
• Corticosteroids should not be used
routinely (unless indicated for other
reasons e.g.: asthma and other
specific conditions); as it has been
associated with:
Prolonged viral clearance
Immunosuppression leading to
bacterial or fungal superinfection.
Prevention
• The most effective way to prevent
the disease is vaccination
• Injected inactivated influenza
vaccines are most commonly used
throughout the world.
• Vaccination is especially important
for people:
At high risk of
influenza complications
Who live with or care for
the people at high risk
WHO recommends annual vaccination for:
• Pregnant women at any stage of pregnancy
• Children aged between 6 months to 5 yrs.
• Elderly individuals (aged more than 65yrs.
• Individuals with chronic medical conditions
• Health-care workers.
• Personal protective measures
Regular hand washing
Good respiratory hygiene
Early self-isolation of those feeling unwell,
feverish and having other symptoms of influenza
Avoiding close contact with sick people
Avoiding touching one’s eyes, nose or
mouth
Antiviral Treatment Recommendations
for Seasonal Influenza
Patient with Assess clinically
Flu Symptoms and investigate